Peregrine Pharma New (PPHM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PPHM | AZN | AMGN | GILD | BMY |
| Company | Peregrine Pharma New | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 4.24 | 169.84 | 372.73 | 130.93 | 61.94 |
| High | 4.25 | 170.26 | 379.41 | 131.65 | 62.82 |
| Low | 4.18 | 168.33 | 372.16 | 129.04 | 61.60 |
| Latest | 4.22 | 169.26 | 376.04 | 129.31 | 62.09 |
| Change | +0.03 | +0.99 | +4.54 | -1.55 | +0.58 |
| % Change | +0.72% | +0.59% | +1.22% | -1.18% | +0.94% |
| Volume | 93,000 | 2,009,900 | 2,493,900 | 5,529,700 | 12,071,700 |
| 20-Day Average Volume | 254,905 | 2,751,260 | 2,287,685 | 7,392,090 | 10,999,955 |
| Previous Close | 4.19 | 168.27 | 371.50 | 130.86 | 61.51 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 4.24 | 177.62 | 365.10 | 131.10 | 58.89 |
| 20-Day Raw Stochastic | 27.59% | 16.07% | 86.76% | 31.18% | 90.16% |
| 20-Day Relative Strength | 48.73 | 42.68 | 61.70 | 48.22 | 60.76 |
| Weighted Alpha | +32.90 | +5.65 | +24.85 | +7.75 | +30.62 |
| Today's Opinion | N/A | 88% Sell | 88% Buy | 56% Sell | 72% Buy |
| Previous Opinion | N/A | 88% Sell | 72% Buy | 24% Sell | 72% Buy |
| Last Month's Opinion | N/A | 40% Sell | 40% Buy | 72% Sell | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.76% since 12/29/17 | +0.21% since 07/17/26 | +2.66% since 07/17/26 | -3.70% since 07/17/26 | +2.22% since 07/17/26 |
| Low | 3.88 on 01/02/18 | 164.06 on 07/20/26 | 359.21 on 07/23/26 | 127.61 on 07/23/26 | 59.80 on 07/21/26 |
| High | 4.25 on 01/05/18 | 170.89 on 07/22/26 | 379.41 on 07/24/26 | 135.50 on 07/20/26 | 62.82 on 07/24/26 |
| 1-Month | |||||
| %Chg | -19.77% since 12/05/17 | -7.52% since 06/24/26 | +7.00% since 06/24/26 | +3.32% since 06/24/26 | +12.89% since 06/24/26 |
| Low | 3.74 on 12/21/17 | 164.06 on 07/20/26 | 350.06 on 06/25/26 | 123.67 on 06/25/26 | 55.02 on 06/25/26 |
| High | 5.48 on 12/11/17 | 196.41 on 07/02/26 | 379.41 on 07/24/26 | 140.61 on 07/17/26 | 62.82 on 07/24/26 |
| 3-Month | |||||
| %Chg | +23.39% since 10/05/17 | -10.80% since 04/24/26 | +9.14% since 04/24/26 | -0.84% since 04/24/26 | +5.76% since 04/24/26 |
| Low | 3.28 on 10/09/17 | 164.06 on 07/20/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 5.48 on 12/11/17 | 196.41 on 07/02/26 | 379.41 on 07/24/26 | 140.61 on 07/17/26 | 62.82 on 07/24/26 |
| 6-Month | |||||
| %Chg | -4.31% since 07/05/17 | -8.95% since 01/23/26 | +9.08% since 01/23/26 | -4.87% since 01/23/26 | +13.61% since 01/23/26 |
| Low | 2.85 on 09/08/17 | 164.06 on 07/20/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 5.78 on 07/14/17 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 190,786 | 262,506,688 | 202,951,808 | 160,547,408 | 126,792,192 |
| Shares Outstanding, K | 45,210 | 1,550,908 | 539,708 | 1,241,570 | 2,042,071 |
| Annual Sales | 57,630,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -28,160,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 12,780,000 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -12,620,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 2.74 | 0.24 | 0.41 | 0.32 | 0.23 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 09/11/17 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 03/12/18 | 07/27/26 | 08/04/26 | 08/04/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | 0.630 on 07/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 07/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.17 | 16.81 | 15.63 | 10.37 |